US OptionsDetailed Quotes
TGTX250502P40500
- 0.07
- -0.83-92.22%
15min DelayClose Apr 30 16:00 ET
0.07High0.07Low
0.07Open0.90Pre Close10 Volume55 Open Interest40.50Strike Price70.00Turnover140.08%IV11.16%PremiumMay 2, 2025Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.07Extrinsic Value100Contract SizeAmericanOptions Type-0.1099Delta0.0416Gamma182.04Leverage Ratio-0.2031Theta-0.0003Rho-20.00Eff Leverage0.0061Vega
TG Therapeutics Stock Discussion
Game-Changing MS Treatment? BRIUMVI Single-Dose Trial Reveals Breakthrough Potential
Game-Changing MS Treatment: BRIUMVI Reveals Exceptional Real-World Safety Profile
Medical Journals Reveal Breakthrough: BRIUMVI Succeeds Where Other MS Treatments Fall Short
How TG Therapeutics Transformed from Clinical-Stage to Profitable Biotech with 250% Revenue Growth
Can BRIUMVI Succeed Where Other MS Treatments Failed? New Clinical Data Reveals Promising Results
Larger Image: tradingview.com...
$TG Therapeutics (TGTX.US)$
No comment yet